Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam effects on neurological function in eloquent area glioma
NCT02439164Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- May 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of midazolam in glioma (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Task Completing Time Change Measured by 9-hole Peg Test. Started May 2015; status: completed.
02
Drugs
midazolam
03
Conditions
glioma
Beyond the preview
Go deeper on NCT02439164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02439164.